详细MR成像报告的原发肿瘤与淋巴结信息对鼻咽癌调强放疗后预后列线图的价值
基于595例2010至2012年在中山大学肿瘤防治中心接受调强放疗的鼻咽癌患者回顾性研究,利用临床特征和原发肿瘤及区域淋巴结的详细MRI表现建立预后列线图。列线图在预测总生存和无进展生存方面优于临床特征联合TNM分类的模型,并经bootstrap重采样和241例队列验证。
要点
- 详细MRI原发肿瘤和淋巴结表现可提升鼻咽癌调强放疗后预后列线图性能。
- 列线图纳入年龄、EBV DNA拷贝数及TVP、MPL、PS、PVS、BOSB、PNS受累等MRI特征。
- 列线图预测总生存和无进展生存优于临床特征联合TNM分类模型。
核心结论
- 原发肿瘤和区域淋巴结的详细MRI表现可改善鼻咽癌患者预后列线图的性能。
研究设计与样本
- 回顾性研究纳入2010至2012年在中山大学肿瘤防治中心接受调强放疗的595例鼻咽癌患者。
- 总生存列线图基于上述595例患者建立,并用bootstrap重采样和241例患者队列验证。
- 无进展生存预测使用同一数据队列,按3:1分为训练队列558例和验证队列278例。
- 通过一致性指数和校准曲线评估列线图的预测准确性和区分能力,并与临床特征联合TNM分类的列线图比较。
主要发现
- 列线图纳入年龄、治疗前EBV DNA拷贝数、TVP受累、MPL受累、PS受累、PVS受累、BOSB受累、PNS受累、Ⅱ区侧别、RPLN侧别、淋巴结分组、结外肿瘤扩展、对比增强环和淋巴结数目。
- 校准曲线显示列线图预测生存与实际生存一致性良好。
- 总生存和无进展生存列线图优于临床特征联合TNM分类的列线图,结果在验证集中进一步确认。
关键数值与推荐
- 总生存列线图基于595例患者,无进展生存训练队列558例、验证队列278例,验证队列241例。
- 列线图预测与实测生存校准曲线一致性良好。
- 列线图在总生存和无进展生存上优于临床特征联合TNM分类模型。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To establish effective prognostic nomograms using clinical features and detailed magnetic resonance imaging (MRI) findings for primary tumor and regional lymph nodes after intensity-modulated radiotherapy (IMRT) in patients with nasopharyngeal carcinoma. METHOD: The nomogram for overall survival (OS) was based on a retrospective study of 595 patients who underwent IMRT at Sun Yat-sen University Cancer Center from 2010 to 2012. The predictive accuracy and discriminative ability of our nomogram models were determined by concordance index and calibration curve, and were compared with the nomogram models combining clinical features with tumor-node-metastasis (TNM) classification. The results were validated using bootstrap resampling and a cohort study of 241 patients. The same data cohort was used to predict the progress-free survival (PFS) of nasopharyngeal carcinoma with 3:1 training cohort (N = 558) and validation cohort (N = 278). RESULTS: The following factors were assembled into our prognostic survival nomogram models: Age, Epstein-Barr virus DNA copy number before treatment (EBV_DNA_CN), tensor veli palatini (TVP) involvement, musculus pterygoideus lateralis (MPL) involvement, prestyloid space (PS) involvement, prevertebral space (PVS) involvement, base of sphenoid bone (BOSB) involvement, paranasal sinus (PNS) involvement, the laterality of Ⅱ (Ⅱ_laterality), the laterality of retropharyngeal lymph node (RPLN_laterality), nodal grouping (NG), extranodal neoplastic spread (ENS), contrast-enhancing rim (CER) and Nodal_number. The calibration curves showed good agreement between nomogram-predicted and actual survival. Our nomogram models for OS and PFS, provided better results than the nomogram models combining clinical features with TNM classification. Results were further confirmed in the validation set. CONCLUSION: Detailed MRI findings of primary tumor and regional lymph nodes can improve the performance of prognostic nomograms for patients with nasopharyngeal carcinoma.
引用
- Wan Y, Tian L, Zhang G, et al. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy. Radiother Oncol. 2018. PMID: 30773185. doi:10.1016/j.radonc.2018.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。